MEDP - Medpace HoldingsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $184.30 | Open | |
| Volume | Market Cap | 6.477B | |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Merck Shelves 2... | 04/15/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10... | |
| Global Pre-Clinical Contract Research Se... | 03/18/21 |
| The Pre-Clinical Contract Research Services Market delivers a comprehensive study of the market, including its dynamics, structure, characteristics, K... | |
| Impact Of Covid-19 On Central Lab Market... | 02/23/21 |
| Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be... | |
| Medpace Holdings, Inc. Reports Fourth Qu... | 02/15/21 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced financial results for the fourth quarter and full y... | |
| Insider Selling: Medpace Holdings, Inc. ... | 02/14/21 |
| Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Stephen P. Ewald sold 10,000 shares of the firm???s stock in a transaction on Tuesday, February 9... | |
| The Daily Biotech Pulse: European Regula... | 02/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D ... | |
| The Daily Biotech Pulse: DermTech Soars ... | 02/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X... | |
| The Daily Biotech Pulse: Lilly COVID-19 ... | 02/10/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M... | |
| Contract Research Organization Market to... | 01/11/21 |
| ReportsnReports.com the exclusive leading provider of market research reports published research report on ???China Contract Research Organization (CR... | |
| Insider Selling: Medpace Holdings, Inc. ... | 01/08/21 |
| Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 185,219 shares of the firm???s stock in a transaction dated Thursday, January 7th. Th... | |
| Medpace Holdings, Inc. to Report Fourth ... | 01/05/21 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced that it will report its fourth quarter and fiscal y... | |
| Insider Selling: Medpace Holdings, Inc. ... | 01/01/21 |
| Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 3,547 shares of the firm???s stock in a transaction on Wednesday, December 23rd. The ... | |
| Insider Selling: Medpace Holdings, Inc. ... | 12/15/20 |
| Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Stephen P. Ewald sold 10,000 shares of the company???s stock in a transaction on Thursday, Decemb... | |
| Medpace Holdings, Inc. to Present at the... | 10/29/20 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced that it will present at the following investor conf... | |
| Medpace Holdings, Inc. Reports Third Qua... | 10/26/20 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced financial results for the third quarter ended Septe... | |
| Medpace (NASDAQ:MEDP) Rating Lowered to ... | 10/24/20 |
| Medpace (NASDAQ:MEDP) was downgraded by equities researchers at BidaskClub from a ???strong-buy??? rating to a ???buy??? rating in a research note iss... | |
| TSLA Tumbles After S&P 500 Shun | 09/04/20 |
| TSLA Tumbles After S&P 500 Shun Tyler Durden Fri, 09/04/2020 - 17:27 But, but, but??? everyone was so certain!! S&P Dow Jones Indices have just issued... | |
| Medpace Holdings, Inc. to Report Third Q... | 09/02/20 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced that it will report its third quarter 2020 financia... | |
| The Daily Biotech Pulse: Merck's Breakth... | 07/29/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Capricor Therapeutics Inc (NASDAQ... | |
| 5 Stock Gainers on Tuesday: Kodak, Auror... | 07/28/20 |
| The stock market gainers Tuesday with shares rising are Kodak, Match Group, Medpace, Polaris and Aurora Cannabis. | |
| Medpace EPS beats by $0.28, beats on rev... | 07/27/20 |
| Medpace (NASDAQ:MEDP): Q2 GAAP EPS of $0.64 beats by $0.28. Revenue of $205M (-4.3% Y/Y) beats by $23.83M. Press Release | |
| Medpace Q2 2020 Earnings Preview (NASDAQ... | 07/26/20 |
| Medpace (NASDAQ:MEDP) is scheduled to announce Q2 earnings results on Monday, July 27th, after market close. The consensus EPS Estimate is $0.40 (-50.... | |
| The Daily Biotech Pulse: Midatech Shelve... | 07/23/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: ... | |
| Medpace : Operationalizing Complex Innov... | 07/21/20 |
| One of the FDA's recent initiatives centers on operationalizing complex innovative trial design. The FDA defines complex clinical trial designs as des... | |
| The Future of the Bioanalytical Testing ... | 06/03/20 |
| DUBLIN--(BUSINESS WIRE)--The "Bioanalytical Testing Services Market by Type, Application, End User - Global Forecasts to 2025 " report has been added ... | |
| Medpace (MEDP) Q1 Earnings Miss Estimate... | 04/28/20 |
| Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues... | |
| Medpace : Q1 2020 Earnings Presentation ... | 04/28/20 |
| Q1 2020 FINANCIAL RESULTS APRIL 28, 2020 F O RWA R D L O O K I N G S TAT E M E N T S & ??? | April 28, 2020 | |
| Medpace Holdings, Inc. Reports First Qua... | 04/28/20 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (???Medpace???) today announced financial results for the first quarter ended March... | |
| Medpace Holdings, Inc. to Report First Q... | 04/03/20 |
| CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq:MEDP) (???Medpace???) today announced that it will report its first quarter 2020 financial... | |
| Medpace Holdings, Inc. : Buying pressure... | 03/05/20 |
| Medpace Holdings, Inc. shares have recently benefited from a buyers' comeback, which was accompanied by a rise in volumes and volatility. This situati... | |
| Strong Buy rating | 03/17/21 |
| Credit Suisse maintains Outperform rating and raises Price Target from $178.00 to $181.00 | |
| Buy rating | 02/17/21 |
| Truist Securities maintains Buy rating and raises Price Target from $135.00 to $180.00 | |
| Strong Buy rating | 02/16/21 |
| Credit Suisse maintains Outperform rating and raises Price Target from $155.00 to $178.00 | |
| Date | 2021-04-26 (AMC) | Est. (EPS/Rev.) | $1.00/ 265.28M |
| Actual (EPS/Rev.) | / | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
